专家档案Expert Profiles

专业领域Fields

公共健康、慢病预防、健康服务评价Public health, chronic disease prevention, health service evaluation

参与方向Participation

公共健康贡献类项目评审、研究成果规范化表达Review of public health contribution projects, structured presentation of research outcomes

长期参与公共健康实践项目的研究设计与效果评估，重视数据可解释性和服务场景中的可持续改进。 Has long worked on study design and impact evaluation for public health practice projects, with emphasis on interpretable data and sustainable improvement in service settings.

专业领域Fields

生物统计、真实世界研究、研究质量控制Biostatistics, real-world research, research quality control

参与方向Participation

课题方案评议、数据分析路径审核、成果质量把关Protocol review, data analysis pathway review, research quality assessment

专注医学研究中的统计设计、样本策略和结果解释，能够为临床与公共健康项目提供方法学支持。 Specializes in statistical design, sampling strategy, and result interpretation in medical research, providing methodological support for clinical and public health projects.

专业领域Fields

免疫学、炎症机制、疾病机制研究Immunology, inflammatory mechanisms, disease mechanism research

参与方向Participation

基础医学研究评审、青年学者课题指导Basic medical research review, guidance for young scholar projects

围绕免疫反应、炎症调控和疾病发生机制开展研究评议，注重基础发现与临床问题之间的连接。 Reviews research on immune response, inflammation regulation, and disease mechanisms, with attention to links between basic discoveries and clinical questions.

专业领域Fields

医学伦理、研究合规、受试者保护Medical ethics, research compliance, participant protection

参与方向Participation

伦理审查咨询、评审规则完善、专家回避机制建议Ethics review consultation, review rule refinement, advice on expert recusal mechanisms

关注医学研究中的伦理边界、知情同意和利益冲突管理，支持联盟评审活动形成更清晰的合规流程。 Focuses on ethical boundaries, informed consent, and conflict-of-interest management in medical research, supporting clearer compliance processes in alliance review activities.

专业领域Fields

药物研发、临床评价、转化路径设计Drug development, clinical evaluation, translational pathway design

参与方向Participation

创新药相关项目评审、临床转化可行性论证Review of innovative drug projects, feasibility assessment for clinical translation

主要关注药物研发项目从早期证据到临床评价的关键环节，强调科学依据、风险识别和应用前景的综合判断。 Works on key steps from early evidence to clinical evaluation in drug development, emphasizing evidence base, risk identification, and application prospects.